The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Seizures and Epilepsy in Alzheimer's Disease
Open accessAbstract
SUMMARY: Many studies have shown that patients with Alzheimer's disease (AD) are at increased risk for developing seizures and epilepsy. However, reported prevalence and incidence of seizures and relationship of seizures to disease measures such as severity, outcome, and progression vary widely between studies. We performed a literature review of the available clinical and epidemiological data on the topic of seizures in patients with AD. We review seizure rates and types, risk factors for seizures, electroencephalogram (EEG) studies, and treatment responses. Finally, we consider limitations and methodological issues. There is considerable variability in the reported prevalence and incidence of seizures in patients with AD—with reported lifetime prevalence rates of 1.5–64%. More recent, prospective, and larger studies in general report lower rates. Some, but not all, studies have noted increased seizure risk with increasing dementia severity or with younger age of AD onset. Generalized convulsive seizures are the most commonly reported type, but often historical information is the only basis used to determine seizure type and the manifestation of seizures may be difficult to distinguish from other behaviors common in demented patients. EEG has infrequently been performed and reported. Data on treatment of seizures in AD are extremely limited. Similarly, the relationship between seizures and cognitive impairment in AD is unclear. We conclude that the literature on seizures and epilepsy in AD, including diagnosis, risk factors, and response to treatment suffers from methodological limitations and gaps.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Disorders accompanied by alterations in spine numbers, including neurodegenerative and neuropsychiatric disorders, are frequently associated with the development of anxiety and seizures33 and cognitive decline34.”
From Epigenetic regulation of brain region-specific microglia clearance activity (2018) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Incidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,084
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Palop, J. J., & Mucke, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2583 · Cited by 1,651
How common are the "common" neurologic disorders?
Hirtz, D., Thurman, D. J., Gwinn-Hardy, K., Mohamed, M., Chaudhuri, A. R., & Zalutsky, R. (2007) · Neurology · doi:10.1212/01.wnl.0000252807.38124.a3 · Cited by 1,365
HOW COMMON ARE THE “COMMON” NEUROLOGIC DISORDERS?
Kaplin, A. I., & Williams, M. (2007) · Neurology · doi:10.1212/01.wnl.0000278071.91524.4d · Cited by 1,132
Turski, W. A., Cavalheiro, É. A., Schwarz, M., Czuczwar, S. J., Kleinrok, Z., & Turski, L. (1983) · Behavioural Brain Research · doi:10.1016/0166-4328(83)90136-5 · Cited by 1,114
Brain Inflammation in Epilepsy: Experimental and Clinical Evidence
Vezzani, A., & Granata, T. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00298.x · Cited by 1,049
Apolipoprotein E and Alzheimer disease.
Strittmatter, W. J., & Roses, A. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4725 · Cited by 701
Research works printed but not linked: 1
- 10.1016/S1388-2457(99)00039-5 · DOI
Cited by
Sorted by citations
Items 201–228 of 228
Epilepsy in patients with dementia
Pešlová, E., & Brázdil, M. (2021) · Neurologie pro praxi · doi:10.36290/neu.2020.038
THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
Cloyd, R. (2021) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2021.271
Guekht, A. B. (2015) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-22159-5_14
Larner, A. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139176095.004
Larner, A. J. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139176095.006
Morning facial rash: A clue to night epileptic seizure
Nakagawa, H., & Hamaguchi, S. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.08.007
Kaddumukasa, M., Bongomin, F., Mugenyi, L., Kiyingi, M., Katabira, E. T., & Sajatovic, M. (2022) · Medicine · doi:10.1097/md.0000000000031012
Epilepsy and Neurodegeneration
Retinasamy, T., & Shaikh, M. F. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_23-1
Liew, Y., Arulsamy, A., & Shaikh, M. F. (2023) · Springer eBooks · doi:10.1007/978-981-19-3949-5_50-1
Epilepsy genetics in clinical practice today and for the future
Goldman, A. M., & Noebels, J. L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00033-9 · Cited by 1
Liew, Y., Arulsamy, A., & Shaikh, M. F. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_50
Epilepsy and Neurodegeneration
Retinasamy, T., & Shaikh, M. F. (2024) · Springer eBooks · doi:10.1007/978-981-99-7557-0_23
Epilepsy in alzheimer's disease: pathophysiological mechanisms and diagnostic features
Azhigova, A. M., Konovalova, T. I., & Vlasov, P. N. (2025) · Medical alphabet · doi:10.33667/2078-5631-2025-15-46-50
Multi-task learning identifies shared genetic risk for late-onset epilepsy and alzheimer’s disease
Fu, M., Tran, T., Paşaniuc, B., Vossel, K. A., & Chang, T. S. (2025) · Scientific Reports · doi:10.1038/s41598-025-32329-8
van Nifterick, A. M., Gouw, A. A., van Kesteren, R. E., Scheltens, P., Stam, C. J., & de Haan, W. (2022) · Figshare · doi:10.6084/m9.figshare.20374707
Alzheimer's disease and epileptic activity: uncertainties abound
Devinsky, O. (2026) · The Lancet Neurology · doi:10.1016/s1474-4422(25)00496-x
Yokoi, K., Tsujimoto, M., Suzuki, K., Takeda, A., Horibe, K., Yamaoka, A., Okada, E., Kawakami, O., Katsuno, M., & Arahata, Y. (2026) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2026.100853
Alcantara‐Gonzalez, D., Santiago, E., & Peña‐Ortega, F. (2026) · Frontiers in Dementia · doi:10.3389/frdem.2026.1738954
Epilepsy and EEG abnormalities in neurodegenerative dementias: toward a system epilepsy framework
Manganotti, P., Palacino, F., Pavan, S., & Benussi, A. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1806471
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
Rodriguez, G. A., Aoun, A., Rothenberg, E. F., Shetler, O., Posani, L., Vajram, S. V., Tedesco, T. G., Sharma, A., Fusi, S., & Hussaini, S. A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117505 · Cited by 2
Bergamo, G., Fernandes, M., Maio, S., Albanesi, G., Antonucci, M., Barbaro, I. Y. A. N., Cirillo, F., Fernando, L., Amicucci, G., Centonze, D., et al. (2026) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2026.112237
Evaluation of MPEG-4 AAC Audio Codec Using EEG and EMG Signals for Use with DICOM® Neurophysiology
Galanti, M., Battaglia, F., Gugliandolo, G., Omland, P. M., Nilsen, K. B., Breevoort, S., Herring, M. N., Kurent, J. E., Chen, I.-H. A., Vu, T., et al. (2026) · Journal of Medical Systems · doi:10.1007/s10916-026-02451-9
Maglio, G. M., de Melo, N. C., & de Carvalho, L. M. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06258-0
The Aging Brain and Epilepsy: Current Knowledge and Novel Therapeutic Targets
Löscher, W., & Forcelli, P. A. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100168
Metadata
- Authors
- Friedman, D., Honig, L. S., & Scarmeas, N.
- Affiliations
- NYU Langone Health (US)
- Columbia University Irving Medical Center (US)
- Corresponding author
- Friedman, Daniel
- Venue
- CNS Neuroscience & Therapeutics
- Publisher
- Wiley
- Published
- 2011-06-07
- Volume
- 18
- Issue
- 4
- Pages
- 285-294
- ISSN
- 1755-5930 (ISSN-L)
- 1755-5949
- PMC
- PMC3630499
- OpenAlex
- W1570043013
- Cited by
- 229
- References
- 72
- Citations by year
- 2026: 16 · 2025: 13 · 2024: 18 · 2023: 16 · 2022: 15 · 2021: 33 · 2020: 21 · 2019: 17 · 2018: 18 · 2017: 9 · 2016: 14 · 2015: 13 · 2014: 12 · 2013: 5 · 2012: 9
- FWCI
- 1.09
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- CNS Neuroscience & Therapeutics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P50AG008702)
- National Center for Research Resources (M01RR000645)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, seizures, epilepsy, seizure prevalence, seizure incidence, risk factors, generalized convulsions, EEG, anticonvulsant therapy, dementia severity, cognitive impairment, methodological limitations
- MeSH terms
- Alzheimer Disease, Animals, Cognition Disorders, Electroencephalography, Epilepsy, Humans, Prospective Studies, Retrospective Studies, Risk Factors, Seizures
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
